COMPARISON OF EFFECTIVENESS OF DRUG-ELUTING STENTS VERSUS BARE METAL STENTS IN LARGE CORONARY ARTERIES: A META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS  by Shah, Tejaskumar M. et al.
ACC-i2 with TCT
E200
JACC March 27, 2012
Volume 59, Issue 13
COMPARISON OF EFFECTIVENESS OF DRUG-ELUTING STENTS VERSUS BARE METAL STENTS IN LARGE 
CORONARY ARTERIES: A META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS
i2 Poster Contributions
McCormick Place South, Hall A
Saturday, March 24, 2012, 9:30 a.m.-Noon
Session Title: DES - Clinical
Abstract Category: 16. PCI - DES (clinical/outcomes)
Presentation Number: 2531-391
Authors: Tejaskumar M. Shah, Mukesh Singh, Rachit Shah, Rohit Bhuriya, Param Singh, Vamsi Kodumuri, Sandeep Khosla, Rohit Arora, Chicago 
Medical School/Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA
Background: Drug eluting stent (DES) are established therapy for coronary lesions <3mm in diameter. Recent clinical trials comparing DES to bare 
metal stent (BMS) in large coronaries (>3mm diameter) have yielded mixed results. Hence, we performed this analysis to evaluate the efficacy of 
DES with BMS for patients with large coronaries undergoing percutaneous coronary intervention (PCI). 
Methods: A literature search identified 7 randomized studies including 6507 patients. End points included major adverse cardiovascular events 
(MACE), cardiovascular (CVS) mortality, myocardial infarction (MI), stent thrombosis (ST), target vessel revascularization (TVR) and target lesion 
revascularization (TLR). Combined odds ratios (OR) across all the studies and 95% confidence intervals (CI) were computed. A two-sided alpha error 
<0.05 was considered. 
Results: Clinical outcomes at 6 months and 12 months were analyzed. DES group shown significantly lower MACE [at 6 months (OR: 0.45, CI: 0.26-
0.76, p=0.003) and at 12 months (OR: 0.717, CI: 0.55-0.93, p=0.012)] and TLR [at 6 months (OR: 0.24, CI: 0.19-0.91, p=0.028) and at 12 months 
(OR: 0.54, CI: 0.35-0.83, p=0.005)]. Contrary, rate of MI, ST, CVS mortality and TVR did not differ in either group at six and twelve months. However, 
overall DES was favorable to BMS in large coronaries [at 6 months (OR: 0.47, CI: 0.34-0.64, p<0.001) and at 12 months (OR: 0.71, CI: 0.60-0.83, 
p<0.001)] [Figure].
Conclusion: DESs have favorable outcomes in large coronaries undergoing PCI.
 
